PDLIM7 and nasopharyngeal carcinoma: EBV‐LMP1 was first discovered to localize to the mitochondrial inner membrane and inhibit mPTP opening by binding to ANT1 fixed to m‐state, thereby favoring NPC cell survival and chemoresistance.